A. S. Kolbin & A. A. Kurylev. (2018). What is the role of antineoplastic drug safety in reimbursement decision making? IRBIS LLC.
Chicago Style (17th ed.) CitationA. S. Kolbin and A. A. Kurylev. What Is the Role of Antineoplastic Drug Safety in Reimbursement Decision Making? IRBIS LLC, 2018.
MLA (9th ed.) CitationA. S. Kolbin and A. A. Kurylev. What Is the Role of Antineoplastic Drug Safety in Reimbursement Decision Making? IRBIS LLC, 2018.
Warning: These citations may not always be 100% accurate.